Skip to main content
Top
Published in: Diabetologia 8/2003

01-08-2003 | Article

The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

Authors: K. Sadeharju, M. Knip, M. Hiltunen, H. K. Åkerblom, H. Hyöty

Published in: Diabetologia | Issue 8/2003

Login to get access

Abstract

Aims/hypothesis

Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes.

Methods

Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles.

Results

Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele (p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) (p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects).

Conclusions/interpretation

Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
Literature
1.
go back to reference D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMed
2.
go back to reference Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314–1318PubMed
3.
go back to reference Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138–147PubMed
4.
go back to reference Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982—a survey. Immunol Rev 70:193–218PubMed
5.
go back to reference Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146PubMed
6.
go back to reference Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420–426PubMed
7.
go back to reference Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632 Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630–632
8.
go back to reference Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland—background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76PubMed
9.
go back to reference Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139 Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137–139
10.
go back to reference Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis) Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis)
11.
go back to reference Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139–144PubMed
12.
go back to reference Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed
13.
go back to reference Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271–277PubMed
14.
go back to reference Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652–657PubMed
15.
go back to reference Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302 Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299–302
16.
go back to reference Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509–518PubMed
17.
go back to reference Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243–252PubMed
18.
19.
go back to reference Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106–109CrossRef
20.
go back to reference Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87–93PubMed
21.
go back to reference Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205–238PubMed
22.
go back to reference Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277–279CrossRefPubMed
23.
go back to reference Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23 Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3–23
24.
go back to reference Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516–1526PubMed
Metadata
Title
The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens
Authors
K. Sadeharju
M. Knip
M. Hiltunen
H. K. Åkerblom
H. Hyöty
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1157-x

Other articles of this Issue 8/2003

Diabetologia 8/2003 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.